Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Introduced
Feb 10, 2025
Last Action
Mar 20, 2025
Session
RI 2025
Sponsors
10 primary · 0 co
03/20/2025 Committee recommended measure be held for further study
03/14/2025 Scheduled for hearing and/or consideration (03/20/2025)
02/10/2025 Introduced, referred to Senate Health and Human Services